- Home
- Publications
- Publication Search
- Publication Details
Title
Radiation-induced liver disease in the era of SBRT: a review
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2020-09-05
DOI
10.1080/17474124.2020.1814744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
- (2020) Pei-Chang Lee et al. Cancers
- Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function
- (2019) F. Rassam et al. EUROPEAN RADIOLOGY
- The role of NLRP3 inflammasome activation in radiation damage
- (2019) Jinlong Wei et al. BIOMEDICINE & PHARMACOTHERAPY
- Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)
- (2018) Louise J. Murray et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage
- (2018) Mary Feng et al. JAMA Oncology
- Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases
- (2018) Gracinda Mondlane et al. Radiation Oncology
- Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure
- (2017) Bo Chen et al. MEDICINE
- Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma
- (2017) Baek Gyu Jun et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Hepatic Failure Progression Is Not Hastened in Intermediate-Risk Hepatocellular Carcinoma After Stereotactic Radiation Therapy (SRT) With Functional Treatment Planning
- (2016) V. Kudithipudi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: Relationship to absorbed dose and time course after irradiation
- (2014) Daisuke Okamoto et al. MAGNETIC RESONANCE IMAGING
- BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation
- (2013) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase II Trial of Palliative Radiotherapy for Hepatocellular Carcinoma and Liver Metastases
- (2013) Hany Soliman et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Novel Insights to Pathogenesis, Current Status of Treatment, and Future Directions
- (2012) P.G. Richardson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-Dose Methylprednisolone for Veno-Occlusive Disease of the Liver in Pediatric Hematopoietic Stem Cell Transplantation Recipients
- (2012) Kasiani C. Myers et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy
- (2012) Mary Feng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation Therapy for Hepatocellular Carcinoma
- (2011) Mary Feng et al. SEMINARS IN RADIATION ONCOLOGY
- Hepatic Radiation Toxicity: Avoidance and Amelioration
- (2011) Chandan Guha et al. SEMINARS IN RADIATION ONCOLOGY
- Radiation Therapy for Liver Metastases
- (2011) Tracey E. Schefter et al. SEMINARS IN RADIATION ONCOLOGY
- Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
- (2010) Higinia R. Cárdenes et al. Clinical & Translational Oncology
- Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis
- (2010) Laura Rubbia-Brandt et al. HISTOPATHOLOGY
- Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic Complication
- (2010) Seok Hyun Son et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation-Associated Liver Injury
- (2010) Charlie C. Pan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters
- (2010) Yuji Iimuro et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child–Pugh Grade A cirrhosis
- (2010) Shi-Xiong Liang et al. RADIOTHERAPY AND ONCOLOGY
- Selenium and Vitamin E Modulates Radiation-Induced Liver Toxicity in Pregnant and Nonpregnant Rat: Effects of Colemanite and Hematite Shielding
- (2009) Osman Gençel et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Extrapolation of Normal Tissue Complication Probability for Different Fractionations in Liver Irradiation
- (2009) An Tai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Sinusoidal Obstructive Syndrome Diagnosed With Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging in Patients With Chemotherapy-Treated Colorectal Liver Metastases
- (2008) Janice Ward et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started